Betamethasone 12‐hourly vs 24‐hourly dosing – fetal/neonatal outcomes
Chronic lung disease · women at risk of preterm birth
It is very uncertain whether betamethasone 12‐hourly changes chronic lung disease compared with 24‐hourly dosing – fetal/neonatal outcomes (very low certainty).
1 finding from 1 review
- Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth 2022 · Cochrane Headline outcomes onlyRR 0.77 [0.48, 1.24]1 study · 253 participantsVery low